Level of Middle Cranial Fossa Dura in Patients With Cholesteatoma
- Conditions
- Cholesteatoma, Middle Ear
- Interventions
- Radiation: Multislice computed tomography temporal bone
- Registration Number
- NCT04551612
- Lead Sponsor
- Assiut University
- Brief Summary
Cholesteatoma is a destructive lesion that progressively expands in the middle ear, mastoid or petrous bone and leads to destruction of the nearby structures. Erosion, which is caused by bone resorption of the ossicular chain and otic capsule, may cause hearing loss, vestibular dysfunction, facial paralysis and intracranial manifestations
- Detailed Description
Cholesteatoma has three Classical forms: (1) Congenital, primary or genuine cholesteatoma: occurs behind an intact tympanic membrane. Primary acquired cholesteatoma: looks like a limited diverticulum of the pars flaccida with little or no history of otorrhea. Secondary acquired cholesteatoma: develops with posterosuperior perforations in eardrum and expansion of the disease process into the antrum, mastoid, attic and middle ear. Granulation tissue, polyps and foul- smelling otorrhea are common findings in this type
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- All adults above the age of 18 presented to the Assiut university Clinic with
cholesteatoma will be included in the study.
- Patients with previous mastoid surgery
- Patients with Craniofacial anomalies or cleft lip and palate
- Pediatric populations ≤ 18 years old
- Patients with congenital ear anomalies
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with cholesteatoma Multislice computed tomography temporal bone Patients with cholesteatoma in one ear that will compared with the other healthy one.
- Primary Outcome Measures
Name Time Method Evaluation of the Level of Middle Cranial Fossa Dura in Patients with Cholesteatoma by multislice computed tomography. One year determination the level of tegmen in patients with attico-antral diseases by MSCT
- Secondary Outcome Measures
Name Time Method